Concepedia

Xinlan Lu

XL

Statistics

Publications

24

Citations

866

H-Index

19

Active since

2012

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

University of Technology Sydney

Xi'an Jiaotong University

Chinese Academy of Sciences

Air Force Medical University

Xinlan Lu is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2012–2024

24

Publications

24

Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway

Yarui Li, Dan Guo, Yan Zhao et al. · Cell Death and Disease · 2018 · 128 citations · Full text

, , +17

DANCR promotes HCC progression and regulates EMT by sponging miR‐27a‐3p via ROCK1/LIMK1/COFILIN1 pathway

Yarui Li, Yifei Chen, Dan Zhang et al. · Cell Proliferation · 2019 · 79 citations · Full text

, , +17

Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: Involvement of cell cycle arrest and apoptosis induction

Xinlan Lu, Jin Zeng, Yule Chen et al. · International Journal of Oncology · 2012 · 60 citations · Full text

, , +14

miR-488 acts as a tumor suppressor gene in gastric cancer

Yan Zhao, Guifang Lu, Xiquan Ke et al. · Tumor Biology · 2016 · 56 citations

, , +16

Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action

Mudan Ren, Eileen McGowan, Yarui Li et al. · Frontiers in Pharmacology · 2019 · 52 citations · Full text

, , +12

1–5 of 24